| Role |
Name |
Disclosure |
Details |
| Author | Pamela I Ellsworth, MD, FACS, Associate Professor of Urology, Brown University; Consulting Staff, University Urological Associates | Pfizer Novartis Allergan | Details | | Coauthor | LiAnn N Handel, MD, Staff Physician, Department of Urology, Rhode Island Hospital/Brown Medical School | Nothing to disclose | Details | | Medical Editor | Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | CME Editor | J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center | Terumo Corporation Omeros Corporation | Details | | Chief Editor | Stephen W Leslie, MD, FACS, Founder and Medical Director of the Lorain Kidney Stone Research Center, Clinical Assistant Professor, Department of Urology, Medical College of Ohio | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| LiAnn N Handel, Coauthor |
The contributor discloses no conflict of interest. |
|